Skip to Main Content

Researchers at Harvard University who want to take drug discoveries from the lab to the market may soon get an infusion of cash.

The university plans to announce a partnership Wednesday with Deerfield Management, a health care hedge fund firm that has pledged $100 million to invest in promising potential drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!